Covered recipient · General Payments record
BRENDA GRZENIA
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2023–2024
$1,538.32
- Reported across 60 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,052.74 | 44 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $131.30 | 7 |
| Takeda Pharmaceuticals U.S.A., Inc. | $113.01 | 5 |
| Merck Sharp & Dohme Corporation | $93.49 | 4 |
| JAZZ PHARMACEUTICALS INC. | $75.55 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $70.00 | 3 |
| Regeneron Healthcare Solutions, Inc. | $68.24 | 2 |
| EISAI INC. | $54.35 | 3 |
| GlaxoSmithKline, LLC. | $50.93 | 2 |
| Lilly USA, LLC | $42.82 | 2 |
| E.R. Squibb & Sons, L.L.C. | $34.33 | 1 |
| Janssen Biotech, Inc. | $33.46 | 1 |
| Daiichi Sankyo Inc. | $27.56 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $26.58 | 1 |
| BeiGene USA, Inc. | $25.81 | 1 |
| Rigel Pharmaceuticals, Inc. | $24.82 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $24.52 | 1 |
| AVEO Pharmaceuticals, Inc. | $22.64 | 1 |
| Celltrion USA Inc. | $22.39 | 1 |
| Astellas Pharma US Inc | $22.36 | 1 |
| Gilead Sciences, Inc. | $21.58 | 1 |
| ABBVIE INC. | $19.98 | 1 |
| Pharmacosmos Therapeutics Inc. | $17.63 | 1 |
| Stemline Therapeutics Inc. | $16.12 | 1 |
| Mirati Therapeutics, Inc. | $13.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (44)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.